Discovery Capital Management’s Pfizer PFE Stock Holding History

Discovery Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-954,350	Closed	-$31.7M	–	61
2023 Q3	$31.7M	Buy	+954,350	New	+$33.7M	5.62%	7
2022 Q1	–	Sell	-344,500	Closed	-$20.3M	–	97
2021 Q4	$20.3M	Sell	344,500 -251,600	-42%	-$12.5M	1.53%	15
2021 Q3	$25.6M	Buy	596,100 +263,900	+79%	+$11.7M	1.92%	10
2021 Q2	$13M	Buy	332,200 +177,000	+114%	+$6.88M	0.84%	23
2021 Q1	$5.62M	Buy	+155,200	New	+$5.51M	0.75%	31
2020 Q4	–	Sell	-384,183	Closed	-$13.4M	–	74
2020 Q3	$13.4M	Buy	+384,183	New	+$13.5M	2.05%	18
2016 Q1	–	Sell	-15,373,328	Closed	-$471M	–	120
2015 Q4	$471M	Buy	15,373,328 +5,209,184	+51%	+$164M	5.58%	2
2015 Q3	$303M	Buy	+10,164,144	New	+$326M	3.37%	4

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Discovery Capital Management's PFE Position: Q4 2023 in Review

Discovery Capital Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 954,350 shares — an estimated $31.7M sold.

Discovery Capital Management first reported a position in PFE in Q3 2015 and held it in 8 quarters. The position peaked at $471M in Q4 2015. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Discovery Capital Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Discovery Capital Management sold 954,350 Pfizer shares in Q4 2023, an estimated $31.7M.
Discovery Capital Management first reported a position in Pfizer in Q3 2015 and held it in 8 quarters.
Discovery Capital Management's Pfizer position peaked at $471M in Q4 2015.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Discovery Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.